Background: Type 2 diabetes mellitus requires long-term treatment and self-management. Patients’ beliefs about medication necessity and concerns may influence treatment behavior, but their relationship with quality of life may vary across populations. Objective: This study examined the relationship between medication beliefs and quality of life among patients with type 2 diabetes mellitus at Kemalang Public Health Center, Klaten, in 2026. Methods: An analytical quantitative approach with a cross-sectional design was employed, involving 78 respondents who satisfied the inclusion criteria and were recruited through purposive sampling. The 10-item Beliefs about Medicines Questionnaire (BMQ) was used to measure medication beliefs, whereas quality of life was evaluated using the WHOQOL-BREF instrument. A p-value below 0.05 was considered statistically significant. Results: The sample was predominantly composed of individuals aged 36-60 years (57.7%) and female participants (73.1%). Positive medication beliefs were observed in the majority of respondents (82.1%), while the necessity and concern belief dimensions were largely categorized as moderate, at 79.5% and 87.2% respectively. Good quality of life was reported by 75.6% of participants, although clinical outcomes remained uncontrolled in 74.4% of cases. Bivariate testing revealed no statistically significant association between medication beliefs and quality of life (LR=1.722; p=0.787). Conclusion: No significant relationship was found between medication beliefs and quality of life. This suggests quality of life is a multidimensional construct likely shaped by clinical, psychological, behavioral, and social factors extending beyond medication beliefs.